Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients

Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor, and no effective treatment is available to date. Mouse models of SCLC based on the inactivation of Rb1 and Trp53 show frequent amplifications of the Nfib and Mycl genes. Here, we report that, although overexpression of either trans...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Cell reports (Cambridge) Ročník 16; číslo 3; s. 631 - 643
Hlavní autori: Semenova, Ekaterina A., Kwon, Min-chul, Monkhorst, Kim, Song, Ji-Ying, Bhaskaran, Rajith, Krijgsman, Oscar, Kuilman, Thomas, Peters, Dennis, Buikhuisen, Wieneke A., Smit, Egbert F., Pritchard, Colin, Cozijnsen, Miranda, van der Vliet, Jan, Zevenhoven, John, Lambooij, Jan-Paul, Proost, Natalie, van Montfort, Erwin, Velds, Arno, Huijbers, Ivo J., Berns, Anton
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Elsevier Inc 19.07.2016
Cell Press
Elsevier
Predmet:
ISSN:2211-1247, 2211-1247
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor, and no effective treatment is available to date. Mouse models of SCLC based on the inactivation of Rb1 and Trp53 show frequent amplifications of the Nfib and Mycl genes. Here, we report that, although overexpression of either transcription factor accelerates tumor growth, NFIB specifically promotes metastatic spread. High NFIB levels are associated with expansive growth of a poorly differentiated and almost exclusively E-cadherin (CDH1)-negative invasive tumor cell population. Consistent with the mouse data, we find that NFIB is overexpressed in almost all tested human metastatic high-grade neuroendocrine lung tumors, warranting further assessment of NFIB as a tumor progression marker in a clinical setting. [Display omitted] •NFIB drives tumor initiation and progression in mouse models of SCLC•NFIB enhances metastasis and changes the metastatic profile•NFIB promotes dedifferentiation and invasion in SCLC•NFIB marks stage III/IV high-grade neuroendocrine carcinomas in patients SCLC is a highly malignant cancer with an unmet need for better intervention strategies. Semenova et al. report that the transcription factor NFIB drives SCLC growth and metastasis, defines an aggressive tumor compartment in mice, and marks a subgroup of high-grade pulmonary neuroendocrine tumors (pNETs) in patients.
AbstractList Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor, and no effective treatment is available to date. Mouse models of SCLC based on the inactivation of Rb1 and Trp53 show frequent amplifications of the Nfib and Mycl genes. Here, we report that, although overexpression of either transcription factor accelerates tumor growth, NFIB specifically promotes metastatic spread. High NFIB levels are associated with expansive growth of a poorly differentiated and almost exclusively E-cadherin (CDH1)-negative invasive tumor cell population. Consistent with the mouse data, we find that NFIB is overexpressed in almost all tested human metastatic high-grade neuroendocrine lung tumors, warranting further assessment of NFIB as a tumor progression marker in a clinical setting.
Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor, and no effective treatment is available to date. Mouse models of SCLC based on the inactivation of Rb1 and Trp53 show frequent amplifications of the Nfib and Mycl genes. Here, we report that, although overexpression of either transcription factor accelerates tumor growth, NFIB specifically promotes metastatic spread. High NFIB levels are associated with expansive growth of a poorly differentiated and almost exclusively E-cadherin (CDH1)-negative invasive tumor cell population. Consistent with the mouse data, we find that NFIB is overexpressed in almost all tested human metastatic high-grade neuroendocrine lung tumors, warranting further assessment of NFIB as a tumor progression marker in a clinical setting.Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor, and no effective treatment is available to date. Mouse models of SCLC based on the inactivation of Rb1 and Trp53 show frequent amplifications of the Nfib and Mycl genes. Here, we report that, although overexpression of either transcription factor accelerates tumor growth, NFIB specifically promotes metastatic spread. High NFIB levels are associated with expansive growth of a poorly differentiated and almost exclusively E-cadherin (CDH1)-negative invasive tumor cell population. Consistent with the mouse data, we find that NFIB is overexpressed in almost all tested human metastatic high-grade neuroendocrine lung tumors, warranting further assessment of NFIB as a tumor progression marker in a clinical setting.
Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor, and no effective treatment is available to date. Mouse models of SCLC based on the inactivation of Rb1 and Trp53 show frequent amplifications of the Nfib and Mycl genes. Here, we report that, although overexpression of either transcription factor accelerates tumor growth, NFIB specifically promotes metastatic spread. High NFIB levels are associated with expansive growth of a poorly differentiated and almost exclusively E-cadherin (CDH1)-negative invasive tumor cell population. Consistent with the mouse data, we find that NFIB is overexpressed in almost all tested human metastatic high-grade neuroendocrine lung tumors, warranting further assessment of NFIB as a tumor progression marker in a clinical setting. • NFIB drives tumor initiation and progression in mouse models of SCLC • NFIB enhances metastasis and changes the metastatic profile • NFIB promotes dedifferentiation and invasion in SCLC • NFIB marks stage III/IV high-grade neuroendocrine carcinomas in patients SCLC is a highly malignant cancer with an unmet need for better intervention strategies. Semenova et al. report that the transcription factor NFIB drives SCLC growth and metastasis, defines an aggressive tumor compartment in mice, and marks a subgroup of high-grade pulmonary neuroendocrine tumors (pNETs) in patients.
Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor, and no effective treatment is available to date. Mouse models of SCLC based on the inactivation of Rb1 and Trp53 show frequent amplifications of the Nfib and Mycl genes. Here, we report that, although overexpression of either transcription factor accelerates tumor growth, NFIB specifically promotes metastatic spread. High NFIB levels are associated with expansive growth of a poorly differentiated and almost exclusively E-cadherin (CDH1)-negative invasive tumor cell population. Consistent with the mouse data, we find that NFIB is overexpressed in almost all tested human metastatic high-grade neuroendocrine lung tumors, warranting further assessment of NFIB as a tumor progression marker in a clinical setting. [Display omitted] •NFIB drives tumor initiation and progression in mouse models of SCLC•NFIB enhances metastasis and changes the metastatic profile•NFIB promotes dedifferentiation and invasion in SCLC•NFIB marks stage III/IV high-grade neuroendocrine carcinomas in patients SCLC is a highly malignant cancer with an unmet need for better intervention strategies. Semenova et al. report that the transcription factor NFIB drives SCLC growth and metastasis, defines an aggressive tumor compartment in mice, and marks a subgroup of high-grade pulmonary neuroendocrine tumors (pNETs) in patients.
Author Pritchard, Colin
Berns, Anton
Proost, Natalie
Krijgsman, Oscar
Zevenhoven, John
Bhaskaran, Rajith
Velds, Arno
Kuilman, Thomas
Peters, Dennis
Cozijnsen, Miranda
Kwon, Min-chul
Song, Ji-Ying
Smit, Egbert F.
Lambooij, Jan-Paul
van der Vliet, Jan
Buikhuisen, Wieneke A.
Huijbers, Ivo J.
Monkhorst, Kim
Semenova, Ekaterina A.
van Montfort, Erwin
AuthorAffiliation 3 Division of Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
6 Division of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
9 Skolkovo Institute of Science and Technology, Moscow 143026, Russia
1 Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
7 Mouse Clinic for Cancer and Aging research Transgenic Core Facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
4 Core Facility for Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
2 Division of Pathology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
5 Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
8 Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
AuthorAffiliation_xml – name: 2 Division of Pathology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– name: 7 Mouse Clinic for Cancer and Aging research Transgenic Core Facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– name: 1 Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– name: 4 Core Facility for Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– name: 5 Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– name: 8 Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– name: 9 Skolkovo Institute of Science and Technology, Moscow 143026, Russia
– name: 3 Division of Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– name: 6 Division of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
Author_xml – sequence: 1
  givenname: Ekaterina A.
  surname: Semenova
  fullname: Semenova, Ekaterina A.
  organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 2
  givenname: Min-chul
  surname: Kwon
  fullname: Kwon, Min-chul
  organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 3
  givenname: Kim
  surname: Monkhorst
  fullname: Monkhorst, Kim
  organization: Division of Pathology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 4
  givenname: Ji-Ying
  surname: Song
  fullname: Song, Ji-Ying
  organization: Division of Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 5
  givenname: Rajith
  surname: Bhaskaran
  fullname: Bhaskaran, Rajith
  organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 6
  givenname: Oscar
  surname: Krijgsman
  fullname: Krijgsman, Oscar
  organization: Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 7
  givenname: Thomas
  surname: Kuilman
  fullname: Kuilman, Thomas
  organization: Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 8
  givenname: Dennis
  surname: Peters
  fullname: Peters, Dennis
  organization: Core Facility for Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 9
  givenname: Wieneke A.
  surname: Buikhuisen
  fullname: Buikhuisen, Wieneke A.
  organization: Division of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 10
  givenname: Egbert F.
  surname: Smit
  fullname: Smit, Egbert F.
  organization: Division of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 11
  givenname: Colin
  surname: Pritchard
  fullname: Pritchard, Colin
  organization: Mouse Clinic for Cancer and Aging research Transgenic Core Facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 12
  givenname: Miranda
  surname: Cozijnsen
  fullname: Cozijnsen, Miranda
  organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 13
  givenname: Jan
  surname: van der Vliet
  fullname: van der Vliet, Jan
  organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 14
  givenname: John
  surname: Zevenhoven
  fullname: Zevenhoven, John
  organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 15
  givenname: Jan-Paul
  surname: Lambooij
  fullname: Lambooij, Jan-Paul
  organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 16
  givenname: Natalie
  surname: Proost
  fullname: Proost, Natalie
  organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 17
  givenname: Erwin
  surname: van Montfort
  fullname: van Montfort, Erwin
  organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 18
  givenname: Arno
  surname: Velds
  fullname: Velds, Arno
  organization: Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 19
  givenname: Ivo J.
  surname: Huijbers
  fullname: Huijbers, Ivo J.
  email: i.huijbers@nki.nl
  organization: Mouse Clinic for Cancer and Aging research Transgenic Core Facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
– sequence: 20
  givenname: Anton
  surname: Berns
  fullname: Berns, Anton
  email: a.berns@nki.nl
  organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27373156$$D View this record in MEDLINE/PubMed
BookMark eNqFUsFuEzEQXaEiWkr_ACEfuSTYXtub5YAEKYFICVSinK1ZezY4bOzU3kRC6sfXS1LUcgBr5LE9895Y8-Z5ceKDx6J4yeiYUaberMcGu4jbMc-3Mc3G6ZPijHPGRoyL6uTB-bS4SGlN81KUsVo8K055VVYlk-qsuL2O4JOJbtu74MkMTB8i-TKbfyDzRIBcRrfHSEJLvm2g68gU87bY-RWZgjc5chXDKmJKA9p5snQGCXhLlhB_JrLEHlIPvTPk0iWEhEPSVX5A36cXxdMWuoQXR39efJ99vJ5-Hi2-fppP3y9GRtayH4mmsWXdgORY17W1qqnqCcPKVpxSIyZCWIOGtkxmJ3LU1LaxAMK2lLKqKc-L-YHXBljrbXQbiL90AKd_P4S40hDzHzvU1EgUjbSAjAnDy0mpaguTRiJV0LYsc707cG13zQZzYd9H6B6RPo5490Ovwl6LWirFqkzw-kgQw80OU683LmU1O_AYdkmzCVWiVJLxnPrqYa0_Re7lywlvDwkmhpQittq4odthKO06zagexkWv9WFc9DAummbjNIPFX-B7_v_Ajg3ArNjeYdTJZDUNWhfR9Lml7t8Ed8ft3OA
CitedBy_id crossref_primary_10_1016_j_jgg_2020_07_001
crossref_primary_10_1038_s12276_019_0349_5
crossref_primary_10_1038_s41467_019_13295_y
crossref_primary_10_1038_s41467_023_40846_1
crossref_primary_10_1007_s10529_017_2428_9
crossref_primary_10_1016_j_jtho_2020_01_016
crossref_primary_10_1016_j_neuron_2025_08_003
crossref_primary_10_3390_ijms21144934
crossref_primary_10_1016_j_ccell_2021_06_016
crossref_primary_10_1177_1533033819874802
crossref_primary_10_1101_gad_338228_120
crossref_primary_10_1016_j_jtho_2024_03_023
crossref_primary_10_1016_j_omto_2019_12_009
crossref_primary_10_1111_pcmr_12710
crossref_primary_10_1038_s43018_022_00361_6
crossref_primary_10_3390_cancers17020255
crossref_primary_10_1158_1541_7786_MCR_23_0002
crossref_primary_10_1038_s41388_021_02070_3
crossref_primary_10_1016_j_semcancer_2020_11_006
crossref_primary_10_1016_j_ebiom_2017_05_027
crossref_primary_10_1080_15384101_2019_1578145
crossref_primary_10_1002_1878_0261_12608
crossref_primary_10_1016_j_jddst_2024_105933
crossref_primary_10_1111_apm_12828
crossref_primary_10_1158_2159_8290_CD_18_0385
crossref_primary_10_7554_eLife_50616
crossref_primary_10_1016_j_jgg_2021_05_007
crossref_primary_10_1093_brain_awae366
crossref_primary_10_1038_s41556_023_01241_6
crossref_primary_10_15252_emmm_202013162
crossref_primary_10_1002_path_5109
crossref_primary_10_3390_cancers16183152
crossref_primary_10_3390_cancers13010014
crossref_primary_10_1038_s41467_023_35864_y
crossref_primary_10_1158_2159_8290_CD_17_0987
crossref_primary_10_1016_j_biopha_2021_111450
crossref_primary_10_1146_annurev_cancerbio_030419_033413
crossref_primary_10_1186_s12943_024_01953_9
crossref_primary_10_1002_path_5182
crossref_primary_10_3389_fonc_2023_1075385
crossref_primary_10_1007_s10555_024_10220_8
crossref_primary_10_1038_s41568_025_00803_0
crossref_primary_10_1080_14728222_2020_1732353
crossref_primary_10_3389_fonc_2024_1509183
crossref_primary_10_1016_j_jbc_2023_105193
crossref_primary_10_1038_nrclinonc_2016_203
crossref_primary_10_1038_s41388_025_03481_2
crossref_primary_10_1038_s43018_019_0020_z
crossref_primary_10_1016_j_jtho_2022_11_019
crossref_primary_10_1007_s13721_018_0173_1
crossref_primary_10_1177_00368504251345012
crossref_primary_10_1002_1878_0261_12829
crossref_primary_10_1016_j_jhep_2017_06_007
crossref_primary_10_1073_pnas_1821893117
crossref_primary_10_3390_ijms20246296
crossref_primary_10_1038_s41467_025_60141_5
crossref_primary_10_1080_15384101_2017_1339849
crossref_primary_10_1111_1759_7714_14574
crossref_primary_10_1158_0008_5472_CAN_23_1079
crossref_primary_10_1007_s12038_019_9903_5
crossref_primary_10_3322_caac_21785
crossref_primary_10_1016_j_jtho_2017_02_008
crossref_primary_10_1158_2159_8290_CD_22_0620
crossref_primary_10_1038_s41388_023_02929_7
crossref_primary_10_1186_s40164_024_00548_w
crossref_primary_10_1111_his_15040
crossref_primary_10_1177_2398212817739433
crossref_primary_10_1016_j_jbc_2023_105124
crossref_primary_10_1038_s41467_023_39291_x
crossref_primary_10_3390_ijms22010027
crossref_primary_10_1038_s12276_022_00905_x
crossref_primary_10_1158_2159_8290_CD_21_0441
crossref_primary_10_1016_j_jtho_2018_02_002
crossref_primary_10_1038_s41416_022_02103_y
crossref_primary_10_1016_j_celrep_2025_115603
crossref_primary_10_1158_1541_7786_MCR_20_1006
crossref_primary_10_1111_cas_15481
crossref_primary_10_1038_s41379_018_0005_y
crossref_primary_10_1186_s40478_021_01299_z
crossref_primary_10_1158_1541_7786_MCR_24_0265
crossref_primary_10_15252_emmm_202013122
crossref_primary_10_1101_gad_349359_122
crossref_primary_10_3390_genes9010012
crossref_primary_10_1016_j_prp_2020_153236
crossref_primary_10_1038_s41572_020_00235_0
crossref_primary_10_1002_cam4_1434
crossref_primary_10_2478_fco_2019_0010
crossref_primary_10_1177_1708538117736695
crossref_primary_10_1093_nsr_nwab232
crossref_primary_10_1016_j_ccell_2016_12_005
crossref_primary_10_1002_cnr2_70018
crossref_primary_10_1016_j_humpath_2018_05_009
crossref_primary_10_1007_s10555_020_09931_5
crossref_primary_10_1038_nrendo_2017_16
crossref_primary_10_3390_cancers10080248
crossref_primary_10_1016_j_ebiom_2017_01_013
crossref_primary_10_1038_s41587_023_01737_4
crossref_primary_10_3389_fcell_2022_825272
crossref_primary_10_1038_nrc_2017_87
crossref_primary_10_1038_s43018_020_0046_2
crossref_primary_10_1109_TCBB_2018_2820695
crossref_primary_10_1002_ijc_30603
crossref_primary_10_3390_ijms25052479
crossref_primary_10_1016_j_lungcan_2020_05_012
crossref_primary_10_1038_s41568_024_00744_0
crossref_primary_10_1016_j_canlet_2017_09_015
crossref_primary_10_1038_s41368_023_00243_2
crossref_primary_10_1016_j_bbagrm_2022_194798
Cites_doi 10.1002/jor.22873
10.1038/nature14664
10.1016/j.cell.2014.02.031
10.1097/JTO.0000000000000459
10.1074/jbc.272.16.10739
10.1002/bies.201400141
10.1101/gad.2046711
10.1038/ng.2405
10.1101/gad.262998.115
10.4297/najms.2011.3227
10.1016/S0378-1119(00)00140-2
10.1097/JTO.0000000000000630
10.3892/or.2016.4621
10.1016/0092-8674(89)90108-6
10.3892/or.2015.3715
10.1111/j.1349-7006.2001.tb01112.x
10.1016/j.molonc.2011.01.006
10.1186/s13059-015-0617-1
10.18632/oncotarget.7047
10.1523/JNEUROSCI.2319-13.2014
10.1242/bio.20147765
10.1002/emmm.201303297
10.1016/j.molonc.2013.02.010
10.1002/gcc.22076
10.1016/j.mcn.2006.10.008
10.1002/gcc.20550
10.1016/S1535-6108(03)00220-4
10.1016/j.cell.2010.11.055
10.1016/j.semcancer.2012.02.012
10.1016/j.ydbio.2011.04.002
10.1101/gad.263145.115
10.1158/0008-5472.CAN-13-3602
10.1016/j.stem.2013.07.002
10.1152/ajplung.00356.2014
10.1038/nprot.2015.114
10.1073/pnas.1410419111
10.1002/cncr.29098
10.1128/MCB.25.2.685-698.2005
10.1002/dvdy.24182
10.1016/j.ccr.2010.12.021
10.1038/nature11847
10.1038/modpathol.2011.150
ContentType Journal Article
Copyright 2016 The Author(s)
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.
2016 The Author(s) 2016
Copyright_xml – notice: 2016 The Author(s)
– notice: Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.
– notice: 2016 The Author(s) 2016
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1016/j.celrep.2016.06.020
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2211-1247
EndPage 643
ExternalDocumentID oai_doaj_org_article_0c5e4b5dae114c238369da8b5e06aff1
PMC4956617
27373156
10_1016_j_celrep_2016_06_020
S2211124716307604
Genre Journal Article
GroupedDBID 0R~
0SF
4.4
457
53G
5VS
6I.
AACTN
AAEDT
AAEDW
AAFTH
AAIKJ
AAKRW
AALRI
AAUCE
AAXJY
AAXUO
ABMAC
ABMWF
ACGFO
ACGFS
ADBBV
ADEZE
AENEX
AEXQZ
AFTJW
AGHFR
AITUG
ALKID
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BCNDV
DIK
EBS
EJD
FCP
FDB
FRP
GROUPED_DOAJ
GX1
IPNFZ
IXB
KQ8
M41
M48
NCXOZ
O-L
O9-
OK1
RCE
RIG
ROL
SSZ
AAMRU
AAYWO
AAYXX
ACVFH
ADCNI
ADVLN
AEUPX
AFPUW
AIGII
AKBMS
AKRWK
AKYEP
APXCP
CITATION
HZ~
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c595t-4bbd39ba52e999dd6b7981e7d7200c4844dcec0f15cec46b7c9dbdaa4df0017b3
IEDL.DBID DOA
ISICitedReferencesCount 120
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000380264200005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2211-1247
IngestDate Fri Oct 03 12:53:34 EDT 2025
Tue Sep 30 16:33:57 EDT 2025
Thu Jul 10 17:11:25 EDT 2025
Thu Apr 03 07:10:04 EDT 2025
Wed Nov 05 20:35:13 EST 2025
Tue Nov 18 21:46:56 EST 2025
Wed May 17 01:06:23 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c595t-4bbd39ba52e999dd6b7981e7d7200c4844dcec0f15cec46b7c9dbdaa4df0017b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Co-senior author
Co-first author
OpenAccessLink https://doaj.org/article/0c5e4b5dae114c238369da8b5e06aff1
PMID 27373156
PQID 1806436512
PQPubID 23479
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_0c5e4b5dae114c238369da8b5e06aff1
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4956617
proquest_miscellaneous_1806436512
pubmed_primary_27373156
crossref_citationtrail_10_1016_j_celrep_2016_06_020
crossref_primary_10_1016_j_celrep_2016_06_020
elsevier_sciencedirect_doi_10_1016_j_celrep_2016_06_020
PublicationCentury 2000
PublicationDate 2016-07-19
PublicationDateYYYYMMDD 2016-07-19
PublicationDate_xml – month: 07
  year: 2016
  text: 2016-07-19
  day: 19
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cell reports (Cambridge)
PublicationTitleAlternate Cell Rep
PublicationYear 2016
Publisher Elsevier Inc
Cell Press
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Cell Press
– name: Elsevier
References Rudin, Durinck, Stawiski, Poirier, Modrusan, Shames, Bergbower, Guan, Shin, Guillory (bib32) 2012; 44
Harris, Genovesi, Gronostajski, Wainwright, Piper (bib15) 2015; 244
Gazdar, Savage, Johnson, Berns, Sage, Linnoila, MacPherson, McFadden, Farago, Jacks (bib10) 2015; 10
Holm, Mader, Haubst, Wizenmann, Sigvardsson, Götz (bib16) 2007; 34
Chang, Pasolli, Giannopoulou, Guasch, Gronostajski, Elemento, Fuchs (bib6) 2013; 495
Semenova, Nagel, Berns (bib34) 2015; 29
Ninkovic, Steiner-Mezzadri, Jawerka, Akinci, Masserdotti, Petricca, Fischer, von Holst, Beckers, Lie (bib29) 2013; 13
Augustyn, Borromeo, Wang, Fujimoto, Shao, Dospoy, Lee, Tan, Sullivan, Larsen (bib2) 2014; 111
Dooley, Winslow, Chiang, Banerji, Stransky, Dayton, Snyder, Senna, Whittaker, Bronson (bib7) 2011; 25
George, Lim, Jang, Cun, Ozretić, Kong, Leenders, Lu, Fernández-Cuesta, Bosco (bib11) 2015; 524
Calbo, van Montfort, Proost, van Drunen, Beverloo, Meuwissen, Berns (bib4) 2011; 19
Ghanem, Fabrice (bib12) 2011; 5
Han, Jung, Cho, Lee, Hwang, Yang, Kang, Bae, Jeon, Park (bib14) 2008; 47
Byers, Rudin (bib3) 2015; 121
Mermod, O’Neill, Kelly, Tjian (bib26) 1989; 58
Stephens, Greenman, Fu, Yang, Bignell, Mudie, Pleasance, Lau, Beare, Stebbings (bib37) 2011; 144
French, Johnatty, Lu, Beesley, Gao, Kalimutho, Henderson, Russell, Kar, Chen (bib9) 2016; 7
Hsu, Osinski, Campbell, Litwack, Wang, Liu, Bachurski, Gronostajski (bib17) 2011; 354
Zhang, Cao, Cheng, Zhang, Jin, Li (bib43) 2015; 33
Iwakawa, Takenaka, Kohno, Shimada, Totoki, Shibata, Tsuta, Nishikawa, Noguchi, Sato-Otsubo (bib20) 2013; 52
Meuwissen, Linn, Linnoila, Zevenhoven, Mooi, Berns (bib27) 2003; 4
Yang, Imoto, Pimkhaokham, Shimada, Sasaki, Oka, Inazawa (bib42) 2001; 92
Kwon, Berns (bib22) 2013; 7
Travis, Brambilla, Nicholson, Yatabe, Austin, Beasley, Chirieac, Dacic, Duhig, Flieder (bib39) 2015; 10
Huijbers, Bin Ali, Pritchard, Cozijnsen, Kwon, Proost, Song, de Vries, Badhai, Sutherland (bib18) 2014; 6
Wang, Huang, Chintagari, Xi, Weng, Liu (bib41) 2015; 309
Piper, Barry, Harvey, McLeay, Smith, Harris, Mason, Stringer, Day, Wray (bib30) 2014; 34
Kuilman, Velds, Kemper, Ranzani, Bombardelli, Hoogstraat, Nevedomskaya, Xu, de Ruiter, Lolkema (bib21) 2015; 16
Singhai, Patil, Jaiswal, Patil, Tayade, Patil (bib35) 2011; 3
McFadden, Papagiannakopoulos, Taylor-Weiner, Stewart, Carter, Cibulskis, Bhutkar, McKenna, Dooley, Vernon (bib25) 2014; 156
Tsai, Bake, Balaraman, Rawlings, Holgate, Dubois, Miranda (bib40) 2014; 3
Huijbers, Del Bravo, Bin Ali, Pritchard, Braumuller, van Miltenburg, Henneman, Michalak, Berns, Jonkers (bib19) 2015; 10
Quattrini, Pollino, Pazzaglia, Conti, Novello, Ferrari, Pignotti, Picci, Benassi (bib31) 2015; 33
Cermáková, Tesina, Demeulemeester, El Ashkar, Méreau, Schwaller, Rezáčová, Veverka, De Rijck (bib5) 2014; 74
Gronostajski (bib13) 2000; 249
Andreasen, Persson, Kiss, Homøe, Heegaard, Stenman (bib1) 2016; 35
Travis (bib38) 2012; 25
Steele-Perkins, Plachez, Butz, Yang, Bachurski, Kinsman, Litwack, Richards, Gronostajski (bib36) 2005; 25
Liu, Bernard, Apt (bib24) 1997; 272
Schneider, Kolligs (bib33) 2015; 37
Mosakhani, Pazzaglia, Benassi, Borze, Quattrini, Picci, Knuutila (bib28) 2013; 28
Ellenbroek, Iden, Collard (bib8) 2012; 22
Kwon, Proost, Song, Sutherland, Zevenhoven, Berns (bib23) 2015; 29
Holm (10.1016/j.celrep.2016.06.020_bib16) 2007; 34
Kuilman (10.1016/j.celrep.2016.06.020_bib21) 2015; 16
Rudin (10.1016/j.celrep.2016.06.020_bib32) 2012; 44
Harris (10.1016/j.celrep.2016.06.020_bib15) 2015; 244
Singhai (10.1016/j.celrep.2016.06.020_bib35) 2011; 3
Meuwissen (10.1016/j.celrep.2016.06.020_bib27) 2003; 4
Quattrini (10.1016/j.celrep.2016.06.020_bib31) 2015; 33
George (10.1016/j.celrep.2016.06.020_bib11) 2015; 524
Augustyn (10.1016/j.celrep.2016.06.020_bib2) 2014; 111
Ellenbroek (10.1016/j.celrep.2016.06.020_bib8) 2012; 22
Piper (10.1016/j.celrep.2016.06.020_bib30) 2014; 34
Chang (10.1016/j.celrep.2016.06.020_bib6) 2013; 495
Kwon (10.1016/j.celrep.2016.06.020_bib22) 2013; 7
Andreasen (10.1016/j.celrep.2016.06.020_bib1) 2016; 35
Han (10.1016/j.celrep.2016.06.020_bib14) 2008; 47
Ghanem (10.1016/j.celrep.2016.06.020_bib12) 2011; 5
Liu (10.1016/j.celrep.2016.06.020_bib24) 1997; 272
McFadden (10.1016/j.celrep.2016.06.020_bib25) 2014; 156
Dooley (10.1016/j.celrep.2016.06.020_bib7) 2011; 25
Huijbers (10.1016/j.celrep.2016.06.020_bib19) 2015; 10
Hsu (10.1016/j.celrep.2016.06.020_bib17) 2011; 354
Schneider (10.1016/j.celrep.2016.06.020_bib33) 2015; 37
Byers (10.1016/j.celrep.2016.06.020_bib3) 2015; 121
Semenova (10.1016/j.celrep.2016.06.020_bib34) 2015; 29
Iwakawa (10.1016/j.celrep.2016.06.020_bib20) 2013; 52
Steele-Perkins (10.1016/j.celrep.2016.06.020_bib36) 2005; 25
Travis (10.1016/j.celrep.2016.06.020_bib38) 2012; 25
Yang (10.1016/j.celrep.2016.06.020_bib42) 2001; 92
Kwon (10.1016/j.celrep.2016.06.020_bib23) 2015; 29
French (10.1016/j.celrep.2016.06.020_bib9) 2016; 7
Stephens (10.1016/j.celrep.2016.06.020_bib37) 2011; 144
Huijbers (10.1016/j.celrep.2016.06.020_bib18) 2014; 6
Mosakhani (10.1016/j.celrep.2016.06.020_bib28) 2013; 28
Travis (10.1016/j.celrep.2016.06.020_bib39) 2015; 10
Cermáková (10.1016/j.celrep.2016.06.020_bib5) 2014; 74
Zhang (10.1016/j.celrep.2016.06.020_bib43) 2015; 33
Mermod (10.1016/j.celrep.2016.06.020_bib26) 1989; 58
Wang (10.1016/j.celrep.2016.06.020_bib41) 2015; 309
Calbo (10.1016/j.celrep.2016.06.020_bib4) 2011; 19
Gronostajski (10.1016/j.celrep.2016.06.020_bib13) 2000; 249
Gazdar (10.1016/j.celrep.2016.06.020_bib10) 2015; 10
Ninkovic (10.1016/j.celrep.2016.06.020_bib29) 2013; 13
Tsai (10.1016/j.celrep.2016.06.020_bib40) 2014; 3
11346465 - Jpn J Cancer Res. 2001 Apr;92(4):423-8
21764851 - Genes Dev. 2011 Jul 15;25(14):1470-5
23389444 - Nature. 2013 Mar 7;495(7439):98-102
22214967 - Mod Pathol. 2012 Jan;25 Suppl 1:S18-30
24630729 - Cell. 2014 Mar 13;156(6):1298-311
23172052 - Histol Histopathol. 2013 May;28(5):671-8
26492136 - Nat Protoc. 2015 Nov;10(11):1755-85
26220992 - Genes Dev. 2015 Jul 15;29(14):1447-62
25887352 - Genome Biol. 2015 Feb 27;16:49
24401838 - EMBO Mol Med. 2014 Feb;6(2):212-25
23933087 - Cell Stem Cell. 2013 Oct 3;13(4):403-18
26883388 - Oncol Rep. 2016 Apr;35(4):2177-82
21215367 - Cell. 2011 Jan 7;144(1):27-40
25764026 - J Orthop Res. 2015 Aug;33(8):1205-11
23716474 - Genes Chromosomes Cancer. 2013 Sep;52(9):802-16
26291008 - J Thorac Oncol. 2015 Sep;10(9):1243-60
23481268 - Mol Oncol. 2013 Apr;7(2):165-77
21316603 - Cancer Cell. 2011 Feb 15;19(2):244-56
26840454 - Oncotarget. 2016 Feb 9;7(6):6353-68
25267614 - Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14788-93
28449525 - J Thorac Dis. 2017 Mar;9(3):E295-E296
15632069 - Mol Cell Biol. 2005 Jan;25(2):685-98
14522252 - Cancer Cell. 2003 Sep;4(3):181-9
21324755 - Mol Oncol. 2011 Apr;5(2):150-5
25063196 - Biol Open. 2014 Jul 25;3(8):741-58
22558599 - N Am J Med Sci. 2011 May;3(5):227-33
25082813 - Cancer Res. 2014 Sep 15;74(18):5139-51
17158062 - Mol Cell Neurosci. 2007 Jan;34(1):99-119
24553933 - J Neurosci. 2014 Feb 19;34(8):2921-30
26215568 - Genes Dev. 2015 Aug 1;29(15):1587-92
25336398 - Cancer. 2015 Mar 1;121(5):664-72
25675280 - J Thorac Oncol. 2015 Apr;10(4):553-64
25591821 - Oncol Rep. 2015 Mar;33(3):1335-41
21513708 - Dev Biol. 2011 Jun 15;354(2):242-52
9099724 - J Biol Chem. 1997 Apr 18;272(16):10739-45
22465739 - Semin Cancer Biol. 2012 Jun;22(3):208-15
22941189 - Nat Genet. 2012 Oct;44(10):1111-6
26071557 - Am J Physiol Lung Cell Mol Physiol. 2015 Aug 15;309(4):L400-13
26168399 - Nature. 2015 Aug 6;524(7563):47-53
2504497 - Cell. 1989 Aug 25;58(4):741-53
25449798 - Bioessays. 2015 Mar;37(3):294-304
25156673 - Dev Dyn. 2015 Mar;244(3):227-38
18314908 - Genes Chromosomes Cancer. 2008 Jun;47(6):490-9
10831836 - Gene. 2000 May 16;249(1-2):31-45
References_xml – volume: 74
  start-page: 5139
  year: 2014
  end-page: 5151
  ident: bib5
  article-title: Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia
  publication-title: Cancer Res.
– volume: 10
  start-page: 1243
  year: 2015
  end-page: 1260
  ident: bib39
  article-title: The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification
  publication-title: J. Thorac. Oncol.
– volume: 272
  start-page: 10739
  year: 1997
  end-page: 10745
  ident: bib24
  article-title: NFI-B3, a novel transcriptional repressor of the nuclear factor I family, is generated by alternative RNA processing
  publication-title: J. Biol. Chem.
– volume: 3
  start-page: 741
  year: 2014
  end-page: 758
  ident: bib40
  article-title: MiR-153 targets the nuclear factor-1 family and protects against teratogenic effects of ethanol exposure in fetal neural stem cells
  publication-title: Biol. Open
– volume: 29
  start-page: 1447
  year: 2015
  end-page: 1462
  ident: bib34
  article-title: Origins, genetic landscape, and emerging therapies of small cell lung cancer
  publication-title: Genes Dev.
– volume: 6
  start-page: 212
  year: 2014
  end-page: 225
  ident: bib18
  article-title: Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells
  publication-title: EMBO Mol. Med.
– volume: 28
  start-page: 671
  year: 2013
  end-page: 678
  ident: bib28
  article-title: MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone
  publication-title: Histol. Histopathol.
– volume: 34
  start-page: 2921
  year: 2014
  end-page: 2930
  ident: bib30
  article-title: NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development
  publication-title: J. Neurosci.
– volume: 249
  start-page: 31
  year: 2000
  end-page: 45
  ident: bib13
  article-title: Roles of the NFI/CTF gene family in transcription and development
  publication-title: Gene
– volume: 7
  start-page: 165
  year: 2013
  end-page: 177
  ident: bib22
  article-title: Mouse models for lung cancer
  publication-title: Mol. Oncol.
– volume: 244
  start-page: 227
  year: 2015
  end-page: 238
  ident: bib15
  article-title: Nuclear factor one transcription factors: divergent functions in developmental versus adult stem cell populations
  publication-title: Dev. Dyn.
– volume: 309
  start-page: L400
  year: 2015
  end-page: L413
  ident: bib41
  article-title: miR-124 regulates fetal pulmonary epithelial cell maturation
  publication-title: Am. J. Physiol. Lung Cell. Mol. Physiol.
– volume: 7
  start-page: 6353
  year: 2016
  end-page: 6368
  ident: bib9
  article-title: Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer
  publication-title: Oncotarget
– volume: 29
  start-page: 1587
  year: 2015
  end-page: 1592
  ident: bib23
  article-title: Paracrine signaling between tumor subclones of mouse SCLC: a critical role of ETS transcription factor Pea3 in facilitating metastasis
  publication-title: Genes Dev.
– volume: 13
  start-page: 403
  year: 2013
  end-page: 418
  ident: bib29
  article-title: The BAF complex interacts with Pax6 in adult neural progenitors to establish a neurogenic cross-regulatory transcriptional network
  publication-title: Cell Stem Cell
– volume: 3
  start-page: 227
  year: 2011
  end-page: 233
  ident: bib35
  article-title: E-Cadherin as a diagnostic biomarker in breast cancer
  publication-title: N. Am. J. Med. Sci.
– volume: 25
  start-page: 685
  year: 2005
  end-page: 698
  ident: bib36
  article-title: The transcription factor gene Nfib is essential for both lung maturation and brain development
  publication-title: Mol. Cell. Biol.
– volume: 25
  start-page: S18
  year: 2012
  end-page: S30
  ident: bib38
  article-title: Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas
  publication-title: Mod. Pathol.
– volume: 156
  start-page: 1298
  year: 2014
  end-page: 1311
  ident: bib25
  article-title: Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing
  publication-title: Cell
– volume: 111
  start-page: 14788
  year: 2014
  end-page: 14793
  ident: bib2
  article-title: ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 22
  start-page: 208
  year: 2012
  end-page: 215
  ident: bib8
  article-title: Cell polarity proteins and cancer
  publication-title: Semin. Cancer Biol.
– volume: 47
  start-page: 490
  year: 2008
  end-page: 499
  ident: bib14
  article-title: DNA copy number alterations and expression of relevant genes in triple-negative breast cancer
  publication-title: Genes Chromosomes Cancer
– volume: 495
  start-page: 98
  year: 2013
  end-page: 102
  ident: bib6
  article-title: NFIB is a governor of epithelial-melanocyte stem cell behaviour in a shared niche
  publication-title: Nature
– volume: 92
  start-page: 423
  year: 2001
  end-page: 428
  ident: bib42
  article-title: A novel amplicon at 9p23 - 24 in squamous cell carcinoma of the esophagus that lies proximal to GASC1 and harbors NFIB
  publication-title: Jpn. J. Cancer Res.
– volume: 35
  start-page: 2177
  year: 2016
  end-page: 2182
  ident: bib1
  article-title: Genomic profiling of a combined large cell neuroendocrine carcinoma of the submandibular gland
  publication-title: Oncol. Rep.
– volume: 4
  start-page: 181
  year: 2003
  end-page: 189
  ident: bib27
  article-title: Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model
  publication-title: Cancer Cell
– volume: 58
  start-page: 741
  year: 1989
  end-page: 753
  ident: bib26
  article-title: The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain
  publication-title: Cell
– volume: 44
  start-page: 1111
  year: 2012
  end-page: 1116
  ident: bib32
  article-title: Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
  publication-title: Nat. Genet.
– volume: 5
  start-page: 150
  year: 2011
  end-page: 155
  ident: bib12
  article-title: Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma
  publication-title: Mol. Oncol.
– volume: 34
  start-page: 99
  year: 2007
  end-page: 119
  ident: bib16
  article-title: Loss- and gain-of-function analyses reveal targets of Pax6 in the developing mouse telencephalon
  publication-title: Mol. Cell. Neurosci.
– volume: 37
  start-page: 294
  year: 2015
  end-page: 304
  ident: bib33
  article-title: E-cadherin’s role in development, tissue homeostasis and disease: insights from mouse models: tissue-specific inactivation of the adhesion protein E-cadherin in mice reveals its functions in health and disease
  publication-title: BioEssays
– volume: 10
  start-page: 553
  year: 2015
  end-page: 564
  ident: bib10
  article-title: The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung
  publication-title: J. Thorac. Oncol.
– volume: 19
  start-page: 244
  year: 2011
  end-page: 256
  ident: bib4
  article-title: A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer
  publication-title: Cancer Cell
– volume: 25
  start-page: 1470
  year: 2011
  end-page: 1475
  ident: bib7
  article-title: Nuclear factor I/B is an oncogene in small cell lung cancer
  publication-title: Genes Dev.
– volume: 16
  start-page: 49
  year: 2015
  ident: bib21
  article-title: CopywriteR: DNA copy number detection from off-target sequence data
  publication-title: Genome Biol.
– volume: 33
  start-page: 1205
  year: 2015
  end-page: 1211
  ident: bib31
  article-title: Prognostic role of nuclear factor/IB and bone remodeling proteins in metastatic giant cell tumor of bone: a retrospective study
  publication-title: J. Orthop. Res.
– volume: 33
  start-page: 1335
  year: 2015
  end-page: 1341
  ident: bib43
  article-title: p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB
  publication-title: Oncol. Rep.
– volume: 52
  start-page: 802
  year: 2013
  end-page: 816
  ident: bib20
  article-title: Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer
  publication-title: Genes Chromosomes Cancer
– volume: 144
  start-page: 27
  year: 2011
  end-page: 40
  ident: bib37
  article-title: Massive genomic rearrangement acquired in a single catastrophic event during cancer development
  publication-title: Cell
– volume: 354
  start-page: 242
  year: 2011
  end-page: 252
  ident: bib17
  article-title: Mesenchymal nuclear factor I B regulates cell proliferation and epithelial differentiation during lung maturation
  publication-title: Dev. Biol.
– volume: 524
  start-page: 47
  year: 2015
  end-page: 53
  ident: bib11
  article-title: Comprehensive genomic profiles of small cell lung cancer
  publication-title: Nature
– volume: 121
  start-page: 664
  year: 2015
  end-page: 672
  ident: bib3
  article-title: Small cell lung cancer: where do we go from here?
  publication-title: Cancer
– volume: 10
  start-page: 1755
  year: 2015
  end-page: 1785
  ident: bib19
  article-title: Using the GEMM-ESC strategy to study gene function in mouse models
  publication-title: Nat. Protoc.
– volume: 33
  start-page: 1205
  year: 2015
  ident: 10.1016/j.celrep.2016.06.020_bib31
  article-title: Prognostic role of nuclear factor/IB and bone remodeling proteins in metastatic giant cell tumor of bone: a retrospective study
  publication-title: J. Orthop. Res.
  doi: 10.1002/jor.22873
– volume: 524
  start-page: 47
  year: 2015
  ident: 10.1016/j.celrep.2016.06.020_bib11
  article-title: Comprehensive genomic profiles of small cell lung cancer
  publication-title: Nature
  doi: 10.1038/nature14664
– volume: 156
  start-page: 1298
  year: 2014
  ident: 10.1016/j.celrep.2016.06.020_bib25
  article-title: Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing
  publication-title: Cell
  doi: 10.1016/j.cell.2014.02.031
– volume: 10
  start-page: 553
  year: 2015
  ident: 10.1016/j.celrep.2016.06.020_bib10
  article-title: The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung
  publication-title: J. Thorac. Oncol.
  doi: 10.1097/JTO.0000000000000459
– volume: 272
  start-page: 10739
  year: 1997
  ident: 10.1016/j.celrep.2016.06.020_bib24
  article-title: NFI-B3, a novel transcriptional repressor of the nuclear factor I family, is generated by alternative RNA processing
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.272.16.10739
– volume: 37
  start-page: 294
  year: 2015
  ident: 10.1016/j.celrep.2016.06.020_bib33
  article-title: E-cadherin’s role in development, tissue homeostasis and disease: insights from mouse models: tissue-specific inactivation of the adhesion protein E-cadherin in mice reveals its functions in health and disease
  publication-title: BioEssays
  doi: 10.1002/bies.201400141
– volume: 25
  start-page: 1470
  year: 2011
  ident: 10.1016/j.celrep.2016.06.020_bib7
  article-title: Nuclear factor I/B is an oncogene in small cell lung cancer
  publication-title: Genes Dev.
  doi: 10.1101/gad.2046711
– volume: 44
  start-page: 1111
  year: 2012
  ident: 10.1016/j.celrep.2016.06.020_bib32
  article-title: Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2405
– volume: 29
  start-page: 1587
  year: 2015
  ident: 10.1016/j.celrep.2016.06.020_bib23
  article-title: Paracrine signaling between tumor subclones of mouse SCLC: a critical role of ETS transcription factor Pea3 in facilitating metastasis
  publication-title: Genes Dev.
  doi: 10.1101/gad.262998.115
– volume: 3
  start-page: 227
  year: 2011
  ident: 10.1016/j.celrep.2016.06.020_bib35
  article-title: E-Cadherin as a diagnostic biomarker in breast cancer
  publication-title: N. Am. J. Med. Sci.
  doi: 10.4297/najms.2011.3227
– volume: 249
  start-page: 31
  year: 2000
  ident: 10.1016/j.celrep.2016.06.020_bib13
  article-title: Roles of the NFI/CTF gene family in transcription and development
  publication-title: Gene
  doi: 10.1016/S0378-1119(00)00140-2
– volume: 10
  start-page: 1243
  year: 2015
  ident: 10.1016/j.celrep.2016.06.020_bib39
  article-title: The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification
  publication-title: J. Thorac. Oncol.
  doi: 10.1097/JTO.0000000000000630
– volume: 35
  start-page: 2177
  year: 2016
  ident: 10.1016/j.celrep.2016.06.020_bib1
  article-title: Genomic profiling of a combined large cell neuroendocrine carcinoma of the submandibular gland
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2016.4621
– volume: 58
  start-page: 741
  year: 1989
  ident: 10.1016/j.celrep.2016.06.020_bib26
  article-title: The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain
  publication-title: Cell
  doi: 10.1016/0092-8674(89)90108-6
– volume: 33
  start-page: 1335
  year: 2015
  ident: 10.1016/j.celrep.2016.06.020_bib43
  article-title: p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2015.3715
– volume: 92
  start-page: 423
  year: 2001
  ident: 10.1016/j.celrep.2016.06.020_bib42
  article-title: A novel amplicon at 9p23 - 24 in squamous cell carcinoma of the esophagus that lies proximal to GASC1 and harbors NFIB
  publication-title: Jpn. J. Cancer Res.
  doi: 10.1111/j.1349-7006.2001.tb01112.x
– volume: 5
  start-page: 150
  year: 2011
  ident: 10.1016/j.celrep.2016.06.020_bib12
  article-title: Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma
  publication-title: Mol. Oncol.
  doi: 10.1016/j.molonc.2011.01.006
– volume: 16
  start-page: 49
  year: 2015
  ident: 10.1016/j.celrep.2016.06.020_bib21
  article-title: CopywriteR: DNA copy number detection from off-target sequence data
  publication-title: Genome Biol.
  doi: 10.1186/s13059-015-0617-1
– volume: 7
  start-page: 6353
  year: 2016
  ident: 10.1016/j.celrep.2016.06.020_bib9
  article-title: Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.7047
– volume: 34
  start-page: 2921
  year: 2014
  ident: 10.1016/j.celrep.2016.06.020_bib30
  article-title: NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.2319-13.2014
– volume: 3
  start-page: 741
  year: 2014
  ident: 10.1016/j.celrep.2016.06.020_bib40
  article-title: MiR-153 targets the nuclear factor-1 family and protects against teratogenic effects of ethanol exposure in fetal neural stem cells
  publication-title: Biol. Open
  doi: 10.1242/bio.20147765
– volume: 6
  start-page: 212
  year: 2014
  ident: 10.1016/j.celrep.2016.06.020_bib18
  article-title: Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells
  publication-title: EMBO Mol. Med.
  doi: 10.1002/emmm.201303297
– volume: 7
  start-page: 165
  year: 2013
  ident: 10.1016/j.celrep.2016.06.020_bib22
  article-title: Mouse models for lung cancer
  publication-title: Mol. Oncol.
  doi: 10.1016/j.molonc.2013.02.010
– volume: 52
  start-page: 802
  year: 2013
  ident: 10.1016/j.celrep.2016.06.020_bib20
  article-title: Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/gcc.22076
– volume: 34
  start-page: 99
  year: 2007
  ident: 10.1016/j.celrep.2016.06.020_bib16
  article-title: Loss- and gain-of-function analyses reveal targets of Pax6 in the developing mouse telencephalon
  publication-title: Mol. Cell. Neurosci.
  doi: 10.1016/j.mcn.2006.10.008
– volume: 47
  start-page: 490
  year: 2008
  ident: 10.1016/j.celrep.2016.06.020_bib14
  article-title: DNA copy number alterations and expression of relevant genes in triple-negative breast cancer
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/gcc.20550
– volume: 4
  start-page: 181
  year: 2003
  ident: 10.1016/j.celrep.2016.06.020_bib27
  article-title: Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(03)00220-4
– volume: 144
  start-page: 27
  year: 2011
  ident: 10.1016/j.celrep.2016.06.020_bib37
  article-title: Massive genomic rearrangement acquired in a single catastrophic event during cancer development
  publication-title: Cell
  doi: 10.1016/j.cell.2010.11.055
– volume: 22
  start-page: 208
  year: 2012
  ident: 10.1016/j.celrep.2016.06.020_bib8
  article-title: Cell polarity proteins and cancer
  publication-title: Semin. Cancer Biol.
  doi: 10.1016/j.semcancer.2012.02.012
– volume: 354
  start-page: 242
  year: 2011
  ident: 10.1016/j.celrep.2016.06.020_bib17
  article-title: Mesenchymal nuclear factor I B regulates cell proliferation and epithelial differentiation during lung maturation
  publication-title: Dev. Biol.
  doi: 10.1016/j.ydbio.2011.04.002
– volume: 29
  start-page: 1447
  year: 2015
  ident: 10.1016/j.celrep.2016.06.020_bib34
  article-title: Origins, genetic landscape, and emerging therapies of small cell lung cancer
  publication-title: Genes Dev.
  doi: 10.1101/gad.263145.115
– volume: 28
  start-page: 671
  year: 2013
  ident: 10.1016/j.celrep.2016.06.020_bib28
  article-title: MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone
  publication-title: Histol. Histopathol.
– volume: 74
  start-page: 5139
  year: 2014
  ident: 10.1016/j.celrep.2016.06.020_bib5
  article-title: Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-13-3602
– volume: 13
  start-page: 403
  year: 2013
  ident: 10.1016/j.celrep.2016.06.020_bib29
  article-title: The BAF complex interacts with Pax6 in adult neural progenitors to establish a neurogenic cross-regulatory transcriptional network
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2013.07.002
– volume: 309
  start-page: L400
  year: 2015
  ident: 10.1016/j.celrep.2016.06.020_bib41
  article-title: miR-124 regulates fetal pulmonary epithelial cell maturation
  publication-title: Am. J. Physiol. Lung Cell. Mol. Physiol.
  doi: 10.1152/ajplung.00356.2014
– volume: 10
  start-page: 1755
  year: 2015
  ident: 10.1016/j.celrep.2016.06.020_bib19
  article-title: Using the GEMM-ESC strategy to study gene function in mouse models
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2015.114
– volume: 111
  start-page: 14788
  year: 2014
  ident: 10.1016/j.celrep.2016.06.020_bib2
  article-title: ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1410419111
– volume: 121
  start-page: 664
  year: 2015
  ident: 10.1016/j.celrep.2016.06.020_bib3
  article-title: Small cell lung cancer: where do we go from here?
  publication-title: Cancer
  doi: 10.1002/cncr.29098
– volume: 25
  start-page: 685
  year: 2005
  ident: 10.1016/j.celrep.2016.06.020_bib36
  article-title: The transcription factor gene Nfib is essential for both lung maturation and brain development
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.25.2.685-698.2005
– volume: 244
  start-page: 227
  year: 2015
  ident: 10.1016/j.celrep.2016.06.020_bib15
  article-title: Nuclear factor one transcription factors: divergent functions in developmental versus adult stem cell populations
  publication-title: Dev. Dyn.
  doi: 10.1002/dvdy.24182
– volume: 19
  start-page: 244
  year: 2011
  ident: 10.1016/j.celrep.2016.06.020_bib4
  article-title: A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2010.12.021
– volume: 495
  start-page: 98
  year: 2013
  ident: 10.1016/j.celrep.2016.06.020_bib6
  article-title: NFIB is a governor of epithelial-melanocyte stem cell behaviour in a shared niche
  publication-title: Nature
  doi: 10.1038/nature11847
– volume: 25
  start-page: S18
  issue: Suppl 1
  year: 2012
  ident: 10.1016/j.celrep.2016.06.020_bib38
  article-title: Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas
  publication-title: Mod. Pathol.
  doi: 10.1038/modpathol.2011.150
– reference: 21764851 - Genes Dev. 2011 Jul 15;25(14):1470-5
– reference: 25764026 - J Orthop Res. 2015 Aug;33(8):1205-11
– reference: 18314908 - Genes Chromosomes Cancer. 2008 Jun;47(6):490-9
– reference: 9099724 - J Biol Chem. 1997 Apr 18;272(16):10739-45
– reference: 22941189 - Nat Genet. 2012 Oct;44(10):1111-6
– reference: 23389444 - Nature. 2013 Mar 7;495(7439):98-102
– reference: 25336398 - Cancer. 2015 Mar 1;121(5):664-72
– reference: 25591821 - Oncol Rep. 2015 Mar;33(3):1335-41
– reference: 22465739 - Semin Cancer Biol. 2012 Jun;22(3):208-15
– reference: 25063196 - Biol Open. 2014 Jul 25;3(8):741-58
– reference: 23716474 - Genes Chromosomes Cancer. 2013 Sep;52(9):802-16
– reference: 25267614 - Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14788-93
– reference: 26840454 - Oncotarget. 2016 Feb 9;7(6):6353-68
– reference: 22214967 - Mod Pathol. 2012 Jan;25 Suppl 1:S18-30
– reference: 25082813 - Cancer Res. 2014 Sep 15;74(18):5139-51
– reference: 21324755 - Mol Oncol. 2011 Apr;5(2):150-5
– reference: 25887352 - Genome Biol. 2015 Feb 27;16:49
– reference: 11346465 - Jpn J Cancer Res. 2001 Apr;92(4):423-8
– reference: 26883388 - Oncol Rep. 2016 Apr;35(4):2177-82
– reference: 28449525 - J Thorac Dis. 2017 Mar;9(3):E295-E296
– reference: 24553933 - J Neurosci. 2014 Feb 19;34(8):2921-30
– reference: 26220992 - Genes Dev. 2015 Jul 15;29(14):1447-62
– reference: 23172052 - Histol Histopathol. 2013 May;28(5):671-8
– reference: 2504497 - Cell. 1989 Aug 25;58(4):741-53
– reference: 26168399 - Nature. 2015 Aug 6;524(7563):47-53
– reference: 25675280 - J Thorac Oncol. 2015 Apr;10(4):553-64
– reference: 21215367 - Cell. 2011 Jan 7;144(1):27-40
– reference: 14522252 - Cancer Cell. 2003 Sep;4(3):181-9
– reference: 21316603 - Cancer Cell. 2011 Feb 15;19(2):244-56
– reference: 22558599 - N Am J Med Sci. 2011 May;3(5):227-33
– reference: 26215568 - Genes Dev. 2015 Aug 1;29(15):1587-92
– reference: 26291008 - J Thorac Oncol. 2015 Sep;10(9):1243-60
– reference: 10831836 - Gene. 2000 May 16;249(1-2):31-45
– reference: 23933087 - Cell Stem Cell. 2013 Oct 3;13(4):403-18
– reference: 17158062 - Mol Cell Neurosci. 2007 Jan;34(1):99-119
– reference: 25156673 - Dev Dyn. 2015 Mar;244(3):227-38
– reference: 21513708 - Dev Biol. 2011 Jun 15;354(2):242-52
– reference: 26071557 - Am J Physiol Lung Cell Mol Physiol. 2015 Aug 15;309(4):L400-13
– reference: 24630729 - Cell. 2014 Mar 13;156(6):1298-311
– reference: 26492136 - Nat Protoc. 2015 Nov;10(11):1755-85
– reference: 15632069 - Mol Cell Biol. 2005 Jan;25(2):685-98
– reference: 25449798 - Bioessays. 2015 Mar;37(3):294-304
– reference: 24401838 - EMBO Mol Med. 2014 Feb;6(2):212-25
– reference: 23481268 - Mol Oncol. 2013 Apr;7(2):165-77
SSID ssj0000601194
Score 2.487832
Snippet Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor, and no effective treatment is available to date. Mouse models of SCLC based on the...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 631
SubjectTerms Animals
Biomarkers, Tumor - metabolism
Cadherins - metabolism
Cell Proliferation - physiology
Disease Models, Animal
Disease Progression
Gene Expression Regulation, Neoplastic - physiology
Humans
Lung Neoplasms - metabolism
Lung Neoplasms - pathology
Mice
Neoplasm Metastasis - pathology
NFI Transcription Factors - metabolism
Proto-Oncogene Proteins c-myc - metabolism
Retinoblastoma Protein - metabolism
Small Cell Lung Carcinoma - metabolism
Small Cell Lung Carcinoma - pathology
Tumor Suppressor Protein p53 - metabolism
Title Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients
URI https://dx.doi.org/10.1016/j.celrep.2016.06.020
https://www.ncbi.nlm.nih.gov/pubmed/27373156
https://www.proquest.com/docview/1806436512
https://pubmed.ncbi.nlm.nih.gov/PMC4956617
https://doaj.org/article/0c5e4b5dae114c238369da8b5e06aff1
Volume 16
WOSCitedRecordID wos000380264200005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2211-1247
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000601194
  issn: 2211-1247
  databaseCode: DOA
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swEBdb2WAvo_tO1xUN9mpmW7JlPa7pwgprCGyDvAl9mXmkzrDTQaF_fO8kOyTbQ172YoMtyz7pdPeTdfodIR-4qCzg_BqQm04TzrgGOwjjymmA47l3rChtSDYh5vNquZSLnVRfGBMW6YFjw31MbeG5KZz2gNwtOBhWSqcrU_i01HUdJj6pkDuTqWiDkcsMl5TzHGO2ci7GfXMhuMv6VeeRrjIrA30npvve8UuBvn_PPf0LP_-OotxxS7Nj8nTAk_RTlOMZeeDb5-RxzDB5-4LcBV80WgY6C9l16Hx2eU4ve6rpRYdxGXRd02_XerWiUw-Hr2AA6BTVoaMLjN-K3B20aekV2BWqW0dxj09Pr_xG45akxtKLuNKDhRaRq7V_SX7MPn-ffkmGhAuJLWSxSbgxjkmji9wDbnSuNEJWmRdOwFiyvOIchLVpnRVw4nDXSmec1tzV6O0Me0WO2nXr3xCaegAHtmRGi4zrVFYucyWrHVSHuT3chLCxuZUd2MgxKcZKjWFnv1TsJIWdpDD6Lk8nJNk-9TuycRwof449uS2LXNrhAmiYGjRMHdKwCRGjHqgBlkS4AVU1B17_flQbBaMWl2J069c3vcoqhIIloK0JeR3VaPuRACgFg2k1vHdPwfak2L_TNj8DMzjOdgGSnvwPsd-SJygK_sfO5Ck52nQ3_h15ZP9smr47Iw_FsjoLg-4eWqswlQ
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transcription+Factor+NFIB+Is+a+Driver+of+Small+Cell+Lung+Cancer+Progression+in+Mice+and+Marks+Metastatic+Disease+in+Patients&rft.jtitle=Cell+reports+%28Cambridge%29&rft.au=Ekaterina%C2%A0A.+Semenova&rft.au=Min-chul+Kwon&rft.au=Kim+Monkhorst&rft.au=Ji-Ying+Song&rft.date=2016-07-19&rft.pub=Elsevier&rft.issn=2211-1247&rft.eissn=2211-1247&rft.volume=16&rft.issue=3&rft.spage=631&rft.epage=643&rft_id=info:doi/10.1016%2Fj.celrep.2016.06.020&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_0c5e4b5dae114c238369da8b5e06aff1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-1247&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-1247&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-1247&client=summon